Corient Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,242
Closed -$98K 768
2021
Q4
$98K Sell
12,242
-1,512
-11% -$12.1K 0.01% 696
2021
Q3
$134K Buy
+13,754
New +$134K 0.01% 669